Scorpion envenomation in children: an analysis of 99 cases

Mehmet Uluğ1, Yöntem Yaman, Ferda Yapici

  • 1Department of Infectious Diseases and Clinic Microbiology, Ozel Omit Hospital, Eskişehir, Turkey.

Insights

Scorpion stings are a significant public health issue, especially for children. This study in Turkey highlights peak sting incidence in July among 6-10 year olds, with most stings on lower limbs, emphasizing the need for health education.

Area of Science:

  • Public Health
  • Epidemiology
  • Toxicology

Background:

  • Scorpion envenomation poses a severe global health threat, disproportionately affecting children.
  • Understanding regional epidemiological patterns is crucial for effective public health interventions.

Purpose of the Study:

  • To delineate the epidemiological profile of scorpion stings in Turkey's southeast Anatolia region.
  • To characterize clinical symptoms, laboratory findings, and patient outcomes.

Main Methods:

  • Retrospective descriptive study design.
  • Analysis of scorpion sting cases from emergency units in Mardin and Midyat.
  • Data collection on demographics, sting location, clinical signs, and outcomes.

Main Results:

  • Peak incidence observed in July (36.4%), coinciding with high temperatures.
  • The 6-10 year age group comprised the majority of cases.
  • Most stings affected exposed extremities (92.9%), primarily lower limbs (58.6%).
  • Common symptoms included local pain, swelling, itching, malaise, dry mouth, sweating, and thirst.
  • Neurological, cardiovascular, and respiratory complications were infrequent.
  • Overall mortality was low (10 per 1000 cases), with one recorded fatality.

Conclusions:

  • Findings provide valuable data for targeted health education and prevention strategies.
  • High incidence during warmer months underscores environmental risk factors.
  • The study emphasizes the importance of prompt medical attention for scorpion envenomation.

Related Concept Videos

Anticholinesterase Agents: Poisoning and Treatment01:26

Anticholinesterase Agents: Poisoning and Treatment

Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Pharmaceutical Poisoning: Treatment Strategies01:26

Pharmaceutical Poisoning: Treatment Strategies

Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Drug Toxicity: Allergic Reactions01:30

Drug Toxicity: Allergic Reactions

Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...